Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program

A.J. van den Eertwegh, P. Karakiewicz, S. Bavbek, S.Y. Rha, S. Bracarda, A. Bahl, Y.C. Ou, D. Kim, A. Panneerselvam, O. Anak, V. Grunwald

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)143-149
Issue number1
Publication statusPublished - 2013

Cite this